Free Trial

Amplifon (OTCMKTS:AMFPF) Shares Gap Up - Should You Buy?

Amplifon logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Shares gapped up — Amplifon opened at $10.49 after closing at $9.46, with 875 shares traded in the move.
  • Analyst sentiment — Jefferies downgraded the stock from "strong-buy" to "hold," while the MarketBeat consensus remains a "Moderate Buy" (two Buys, one Hold).
  • Financial and technicals — Market cap $2.31B and P/E 18.73, but a debt-to-equity of 1.14 and low liquidity ratios (current 0.62, quick 0.54), and the share price sits below its 50‑day ($11.83) and 200‑day ($14.83) moving averages, signaling recent weakness.
  • Interested in Amplifon? Here are five stocks we like better.

Shares of Amplifon S.p.A. (OTCMKTS:AMFPF - Get Free Report) gapped up prior to trading on Wednesday . The stock had previously closed at $9.46, but opened at $10.49. Amplifon shares last traded at $10.49, with a volume of 875 shares traded.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group lowered Amplifon from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 18th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, Amplifon has a consensus rating of "Moderate Buy".

Read Our Latest Stock Analysis on AMFPF

Amplifon Stock Performance

The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.54 and a current ratio of 0.62. The business has a 50-day moving average price of $11.83 and a 200 day moving average price of $14.83. The stock has a market capitalization of $2.31 billion, a P/E ratio of 18.73 and a beta of 0.63.

About Amplifon

(Get Free Report)

Amplifon is a global leader in hearing care, specializing in the retail and distribution of hearing aids, accessories and related services. The company offers a full suite of solutions including diagnostic hearing assessments, personalized hearing aid fittings, follow-up care, tinnitus management and hearing protection. Through its network of branded stores and partner outlets, Amplifon serves individuals across the full spectrum of hearing needs, from prevention and early detection to long-term aftercare.

Founded in Milan in 1950 by Algernon Charles Holland, Amplifon has grown from a single audiology centre into a multinational organization.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amplifon Right Now?

Before you consider Amplifon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amplifon wasn't on the list.

While Amplifon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines